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Rosai–Dorfman disease (RDD) is a benign histio-
cytic proliferative disorder. Clinically, the disease 
is characterized by the presence of massive lym-
phadenopathy mostly involving the cervical lymph
nodes.1 Histologically, the sinuses of the involved
lymph nodes are distended by numerous distinctive
histiocytes. These histiocytes are large and contain
vesicular nuclei, distinct nucleoli and voluminous
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Background/Purpose: Rosai–Dorfman disease (RDD) is a rare histiocytic proliferative disorder that usu-
ally presents as cervical lymphadenopathy. Extranodal involvement occurs in up to 40% of patients. The
 disease is most prevalent in blacks and rare in Asians. This study analyzed the characteristics of RDD in
patients from Taiwan.
Methods:  Fourteen patients with a diagnosis of RDD were identified by review of records from 1995
 to 2004 at National Taiwan University Hospital. Tissue sections from each patient were reviewed and
timmunohistochemical staining was performed. Data on clinical presentations, associated diseases, treatmen
and outcome were analyzed. In situ hybridization for Epstein–Barr virus (EBV)-encoded small RNAs (EBER-1)
was also performed. Sets of primers specific for the conservative region of bacterial 16S-rDNA, IS6110 of
Mycobacterium tuberculosis complex and consensus region of human herpes virus (HHV) DNA polymerase
genome were used to detect the presence of these infectious agents in the specimens.
Results: There were six men and eight women with a mean age of onset of 44 years. Nine patients presented
with skin lesions, four with lymph node involvement and one with nasal tumor. All lesions followed a chronic
and indolent course. Most of the lesions regressed spontaneously, and no patients died as a result of this
disease during follow-up. Three patients had associated immune-mediated disease, i.e. hemolytic anemia,
ankylosing spondylitis and asthma. Two patients had a history of tuberculosis. Histologically, all lesions were
characterized by a mixed infiltrate of large pale histiocytes, abundant plasma cells and lymphocytes regardless
of the site of involvement. The strong immunoreactivities of these histiocytes to S-100 protein, CD68 and
CD14 with occasional lymphophagocytosis were helpful in confirming the diagnosis, polymerase chain reac-
tion analysis of 16S-rDNA, IS6110 and HHV gene and in situ hybridization for EBV were all negative.
Conclusion: RDD in Taiwan is characterized by older age of onset compared to Western countries (44 years
vs. 20 years) and more frequent extranodal involvement. The skin was the most common site of extranodal
finvolvement, with about two-thirds of patients presenting with cutaneous lesions. There was no evidence o
bacterial, mycobacterial or HHV infection in this series. [J Formos Med Assoc 2006;105(9):701–707]
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ORIGINAL ARTICLE
pale cytoplasm, often with lymphophagocytosis.2
In the beginning, the disease was thought to be
confined to the lymph nodes and was thus ini-
tially named sinus histiocytosis with massive
lymphadenopathy.3 With increasing study of this
disease, however, it became evident that extranodal
involvement is not uncommon. Therefore, the term
sinus histiocytosis with massive lymphadenopathy
is now no longer used to describe the disease, and
RDD is considered more suitable for describing 
its presentation with extranodal involvement.4
Although RDD was first identified more than 30
years ago, most of the reported cases have been
from the United States and Western Europe. A dis-
proportionate but high number of cases have been
reported from Africa and the Caribbean region, and
only a few reports have been from Asia.5
This study reviewed the characteristics of 14
cases of RDD diagnosed during the 10-year period
from 1995 to 2004 in a single hospital in Taiwan,
including clinical presentations, associated dis-
eases, histologic findings and outcomes.
Methods
RDD was diagnosed in 14 patients during the 
10-year period from 1995 to 2004 at National
Taiwan University Hospital, a medical center in
northern Taiwan. Information collected by chart
review included demographic characteristics, cli-
nical presentations, laboratory examinations,
course and treatment regimens. Tissue samples
in formalin-fixed and paraffin-embedded blocks
were collected from the archive of the department
of pathology at the same hospital. Routine hema-
toxylin and eosin staining of the recut sections
were reviewed. Immunohistochemical staining
was performed on formalin-fixed, paraffin-
embedded tissue using the avidin–biotin technique
on an automatic immunostainer (BenchMark,
Ventana Medical Systems Inc., Tucson, AZ, USA).
Antibodies against CD20 (L-26, pan-B marker)
(1:100; DAKO, Carpinteria, CA, USA), CD1a
(Langerhans’ cell marker) (1:40; Novocastra,
Newcastle, UK), CD21 (follicular dendritic cell
marker) (1:40; DAKO), S-100 protein (predo-
minant reactivity in Langerhans’ cell) (1:400;
DAKO), CD3 (pan T-cell marker) (1:100; DAKO),
CD14 (lipopolysaccharide receptor on the surface
membrane of macrophages) (1:40; Novocastra),
CD15 (myeloid marker) (LeuM1, 1:50; DAKO),
CD68 (KP-1, macrophage marker) (1:100; DAKO)
and CD123 (expressed mainly in macrophages
such as plasmacytoid dendritic cells) (1:40; BD
PharMingen, Franklin Lakes, NJ, USA) were used.
In situ hybridization for Epstein–Barr virus (EBV)-
encoded small RNAs (EBER-1) was also performed
on formalin-fixed, paraffin-embedded tissue
sections. DNA extracted from paraffin-embedded
 tissue sections was used for polymerase chain
creaction (PCR) analysis. Sets of primers specifi
for the conservative region of bacterial 16S-rDNA,6
IS6110 of Mycobacterium tuberculosis complex7 ro
consensus region of human herpes virus (HHV)
DNA polymerase genome8 twere used to detec
the presence of these agents in the specimens.
Results
tThe 14 patients included six men and eigh
women, with ages ranging from 18 to 68 years
c(mean, 44 years). All lesions followed a chroni
tand indolent course. The duration from the onse
 of disease to diagnosis varied from 2 months
t to 4 years. Out of the 14 patients, 10 underwen
resection or incisional biopsy only without fur-
ther treatment, and four patients received med-
ical treatment due to extensive lesions or the
fpresence of residual lesions. No patients died o
the disease during the study period. Nine patients
had cutaneous or soft-tissue lesions. All of the cu-
taneous lesions presented as nodules or plaques
with discoloration of the skin (Figure 1A). Two
yof the nine patients also had lymphadenopath
fin addition to the skin lesions, but the nature o
lymphadenopathy was unknown because no sur-
gical specimen was taken from these lymph nodes.
Four patients had nodal involvement of RDD
fconfirmed by histologic examination and all o
them presented with neck lymphadenopathy.
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Only one patient presented with a mass lesion in
the nasal cavity and paranasal sinuses (Figure 1B).
Three patients had immunologic disorders includ-
ing asthma, hemolytic anemia and ankylosing
spondylitis. Two patients had tuberculosis many
years before the onset of RDD. The clinical char-
acteristics of each patient are shown in the Table.
Histologically, all lesions showed mixed in-
flammation comprising histiocytes, plasma cells,
lymphocytes and some neutrophils. At low-power
examination, a characteristic pattern of alternating
pale and dark areas was seen in most specimens
(Figure 2A). The clear area was composed of his-
tiocytes with a polygonal shape and abundant
eosinophilic to clear cytoplasm and medium to
large vesicular nuclei. The dark area contained
numerous plasma cells and lymphocytes. Lym-
phophagocytosis by the histiocytes, also called
“emperipolesis”, was present to a variable degree
in all lesions (Figure 2B). In nodal RDD, the char-
acteristic histiocytes filled dilated sinuses, and the
capsule was thickened and fibrotic (Figure 2C).
In cutaneous lesions, inflammation was mainly
located in the mid-dermis. The overlying epider-
mis was not remarkable, presenting without acan-
thosis and spongiosis. 
Immunohistochemically, the infiltrating his-
tiocytes were strongly reactive to S-100 protein
(Figure 3), CD14 and CD68 but negative to CD1a,
CD15, CD21 and CD123 in all specimens. The
ingested lymphocytes within the histiocytes were
either CD3 positive T-cell or CD20 positive B-cell.
Plasma cells were also occasionally seen within
the histiocytes. No sections contained EBER-1
transcript. PCR analysis for bacterial 16S-rDNA,
IS6110 of M. tuberculosis complex and consensus
region of HHV DNA polymerase genome were
negative in all specimens. 
Discussion
RDD was first reported by Rosai and Dorfman in
1969.3 It usually presents as massive, painless,
neck lymph node enlargement. Clinically, RDD
follows a chronic and indolent course. In studies
from Western countries, most cases occurred dur-
ing the first or second decade of life with a mean
age of 20 years.4 In this study, the mean age at dis-
rease onset was 44 years, which is much olde
than that in studies reported from Western coun-
tries. The disorder is often self-limiting and sub-
tject to spontaneous regression. As such, mos
patients do not require therapy other than resec-
tion of the affected tissue. However, some pa-
ytients with extensive or progressive disease ma
require further treatment.9 fIn this series, 10 o  
14 patients underwent excisional biopsy or surgi-
cal resection only without further treatment, and
ymost residual lesions regressed spontaneousl
but slowly. In the remaining four patients with
extensive or multiple lesions, different thera-
peutic regimens were attempted, and most lesions
regressed. However, no definite conclusion con-
cerning the responses to each treatment could be
derived due to limited information. No patients
died of the disease in the follow-up period re-
gardless of the modality of treatment.
fRosai–Dor man disease in Taiwan
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A B iF gure 1. ( )A  Cutaneous
Rosai–Dorfman disease. Papular
lesions developed on an erythe-
matous and hyperpigmented
plaque over the right neck.
(B) Nasal Rosai–Dorfman 
disease. The tumor (white arrow)
developed from the nasal septum
touching the nasal floor and
inferior turbinate (black arrow).
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Table. Clinical and laboratory findings, treatment and outcome of 14 patients with Rosai–Dorfman disease in Taiwan
No.
Age/ Clinical Laboratory Associated clinical
Duration Treatment Outcome
Sex presentation findings conditions
1 53/F Multiple skin lesions EBV study ND Hemolytic anemia 4 yr Prednisolone Partial response
over the extremities Polyclonal Tuberculosis Hydroxychloroquin
Right neck mass gammopathy diagnosed Anti-CD20
12 yr previously
2 25/F Scalp tumor EBV study ND Nil 6 mo Resection No residual 
tumor
3 19/F Left neck mass* EBV IgG: 1:640 (+) Asthma 2 mo Resection No residual
Chronic ulcer tumor
4 68/M Multiple skin nodules Direct Coomb test Nil 2 yr Isotretinoin Lost F/U
Axillary (+) Roaccutane
lymphadenopathy EBV study ND
5 18/M Multiple pigmented EBV IgG: Ankylosing spondylitis 3 yr Prednisolone Regression after
skin lesions over 1:2560 (+) RDD diagnosed in treatment for
the abdomen and younger brother 6 yr
extremities 2 yr before
6 58/M Bilateral neck mass* EBV study ND Nil 3 mo Resection of Lost F/U
left LN
7 23/F Skin lesions over EBV study ND Nil 2 yr Biopsy Lost F/U
the left flank and
deltoid areas
8 61/M Left thigh lesions EBV study ND Nil 4 yr Resection No residual 
Polygammopathy tumor
9 35/F Right shoulder EBV study ND Nil 2–3 mo Dapson Lost F/U
plaque
10 33/F Hyperpigmented skin EBV study ND Tuberculosis 11 mo Biopsy Partial 
lesions on trunk diagnosed spontaneous 
15 yr previously regression
11 53/F Right neck mass* EBV study ND Nil 2 mo Resection No residual 
tumor
12 53/M Nasal tumor EBV IgG: 1:1930 (+) Nil 1 yr Resection of Partial
paranasal and nasal tumor spontaneous
sacral involvement regression
13 58/M Right neck mass* EBV study ND Nil 2 mo Resection No residual
tumor
14 61/F Left thigh nodules EBV study ND Nil 1 yr Biopsy Partial 
spontaneous
regression
*Lymph node involvement of Rosai–Dorfman disease was confirmed by lymphadenectomy. EBV = Epstein–Barr virus; ND = not done; F/U = follow-up.
Up to 40% of cases have extranodal lesions in
the studies from Western countries. Skin, nasal cav-
ities, paranasal sinuses, soft tissue and orbits are the
most common sites of extranodal RDD. In a 423-
case study of RDD by Foucar et al,4 49 cases
(11.6%) had skin involvement, and one-fourth of
them had lymph node involvement simultane-
ously. In this study, out of 14 patients, 10 (71.4%)
had extranodal involvement, of which nine pre-
sented with cutaneous lesions and only one pre-
sented with nasal tumor. Two of the nine patients
with cutaneous RDD also had lymph node enlarge-
ment, but the nature of the enlarged lymph node
was unknown. The etiology of the high prevalence
of extranodal involvement and predominant skin
rmanifestation of RDD in Taiwan is unclear. Simila
observations were also reported by Lu et al.5
Clinically, cutaneous RDD usually presents as
rerythematous or brownish infiltrated nodules o
plaques with surrounding satellite papules. This
must be differentiated from sarcoidosis, deep
rfungal infection, tuberculosis cutis and othe  
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A B
C iF gure 2. ( ) l ll f d hA  Histo ogica y, Rosai–Dor man isease s ows
a characteristic pattern of alternating pale and dark areas on
low-power magnification (hematoxylin & eosin, H&E, 4×).
(B) The clear area is composed of histiocytes with polygo-
nal shapes and abundant clear cytoplasm containing some
lymphocytes (emperipolesis) (H&E, 200×). (C) The involved
lymph node is characterized by dilated sinuses filled with
histiocytes (H&E, 100×).
A B
iF gure 3. h f l h f d h d b ( )T e in i trating istiocytes in Rosai–Dor man isease are c aracterize  y strong reaction to: A  S-100 protein
(arrowheads) (SAB immunohistochemical stain, 400×); and (B) CD14 (SAB immunohistochemical stain, 200×).
cutaneous histiocytosis. The skin of the entire body
can be involved by cutaneous RDD.10,11 The trunk
and extremities were the most commonly involved
sites in our study (8/9) and in two other serial stud-
ies. In contrast, the head and neck were the most
frequently affected sites in the study by Lu et al.5
Histologically, RDD has characteristic fea-
tures regardless of the site involved. Full-blown
lesions are characterized by a mixed, florid in-
filtrate of large pale histiocytes, abundant
plasma cells and lymphocytes. These morpho-
logic features may lead to confusion with other
diseases with histiocytic infiltration such as fun-
gal infection, mycobacterial infection and inflam-
matory pseudotumor. Cutaneous RDD may also 
be confused with xanthomatous lesions such as
xanthogranuloma, fibrohistiocytoma and xan-
thoma.2,12 Immunohistochemical staining is use-
ful in differentiating RDD from these histiocytic
lesions. The histiocytes of RDD are thought to be
activated macrophages derived from circulating
monocytes, and they are usually strongly reactive
to CD68 (a macrophage marker), CD14 and S-100
protein. CD14 is a lipopolysaccharide receptor
expressed on the membrane of macrophages. In
contrast, the histiocytes of xanthomatous lesions
are positive for CD68 but negative for S-100 pro-
tein. RDD may also be confused with Langerhans’
cell histiocytosis because Langerhans’ cells also
express S-100 protein.13 However, the nuclei of
Langerhans’ cells are characterized by the pres-
ence of nuclear grooving, which is rarely seen in
RDD cells. In addition, Langerhans’ cells are re-
active to CD1a, but RDD histiocytes are not.14
Emperipolesis, ingestion of lymphocytes by his-
tiocytes, is found to a variable degree in all le-
sions. The ingested lymphocytes could be B-cells
or T-cells.15 In late or treated cutaneous RDD, the
number of histiocytes decreases. Thus, it is diffi-
cult for the pathologist to make a correct diagno-
sis at this stage. In this situation, S-100 protein
stain is able to highlight the characteristic histio-
cytes and confirm the diagnosis.2 Although the
etiology of RDD remains unknown, infectious
agents have been suspected to be the cause of the
disease because fever and pharyngitis precede its
onset in some patients. Various investigations, in-
xcluding routine and special cultures of oropharyn
or excised tissue, skin tests, serology, electron mi-
croscopy and special histochemical stains, have
been used to determine the possible infectious
agents associated with RDD; however, they all
failed to show direct evidence of specific mi-
croorganisms.4 fIn this study, we used sets o
primers specific for the bacteria 16S-rDNA, IS6110
of M. tuberculosis complex, and the consensus re-
gion of HHV DNA polymerase gene to analyze
the DNA extracted from pathologic specimens.
No PCR product of these infectious agents could
tbe found in any of the specimens. A significan
number of patients with RDD had antibodies to
HHV-6 or EBV.16 Serologic study for EBV was per-
formed in three patients in this series, and all
showed elevated EBV IgG, but no EBV genome
was detected in the tissue sections by in situ hy-
bridization. The absence of herpes viral genome
using PCR analysis in this study further confirms
that EBV seropositivity is more of an epiphe-
nomenon of abnormal immune response, which
is not unusual in patients with RDD. 
Various immune disorders have been repor-
ted to be associated with RDD, among which
themolytic anemia and arthritis are the mos
common.17 Other immunologic disorders such
as asthma and juvenile onset of diabetes mel-
tlitus have also been reported. Thirteen percen
(56/423) of patients in Foucar et al’s4  series had
immune-associated disease. Three patients (21.4%)
in this study had immunologic dysfunction in-
cluding asthma, hemolytic anemia and ankylos-
ing spondylitis. Two of them also had elevated
serum EBV IgG titer. The cause of the association
between RDD and autoimmune disease is un-
clear. Recently, Maric et al18 reported that histo-
logic features of RDD could also be found in the
lymph nodes of some patients with autoimmune
rlymphoproliferative syndrome (ALPS). The latte
is an inherited disorder associated with defects
tin Fas-mediated apoptosis, characterized mos
often by childhood onset of lymphadenopathy,
splenomegaly, hypergammaglobulinemia and
autoimmune phenomena. Some cases of RDD,
C.H. Hsiao, et al
706 J Formos Med Assoc | 2006 • Vol 105 • No 9
particularly those with autoimmune disease, may
be associated with heritable defects in Fas-mediated
apoptosis and have overlap symptoms with ALPS.18
Two of our patients had a history of tubercu-
losis at 15 and 12 years before the onset of RDD,
respectively. These two patients were cured after
a complete course of antituberculous treatment.
Foucar et al4 reported severe streptococcal pneu-
monia in six patients in a registry of 423 patients
with RDD, but no tuberculosis was found in
their study. The reason for the development of
tuberculosis preceding the onset of RDD in the
two patients is unknown; the higher prevalence
of tuberculosis in Taiwan and underlying immune
defect could both have played a role.
Familial RDD was reported in four families
including two twins and two siblings.4 An 18-
year-old male patient (case 5) in this study also
had familial RDD. His younger brother also had
RDD involving the neck lymph node diagnosed
in another hospital 2 years before the develop-
ment of cutaneous RDD. The familial occurrence
of RDD suggests that the disease may be trans-
mitted through close contact. 
In summary, this study found that the biologic
features of RDD in Taiwan are not significantly dif-
ferent from those in Western countries, although
there are still some differences in presentation.
First, the age of onset of RDD in Taiwan (44 years)
is older than that in Western countries (20 years).
Second, extranodal involvement is more common
than pure nodal involvement, and the skin is the
major site of involvement.
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